The FDA declared the Zepbound shortage over—and it’s rattling the weight-loss industry

The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli Lilly’s (LLY) popular diabetes and weight-loss drugs Mounjaro and Zepbound—is officially over.

Read more…

​The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli Lilly’s (LLY) popular diabetes and weight-loss drugs Mounjaro and Zepbound—is officially over.Read more…